Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Lambertini

Showing results (51-60 of 375) with videos related to

Pageof 38
Sort By:
Annals of Palliative Medicine|April 3, 2020
Moving trastuzumab emtansine (T-DM1) to the early setting of breast cancer treatmentLuca Arecco, Eva Blondeaux, Alessandra Damassi, et al.
Breast Care (Basel, Switzerland)|May 14, 2020
Highlights from the San Antonio Breast Cancer Symposium (SABCS) 2019Isabell Witzel, Matteo Lambertini, Marija Balic, et al.
International Journal of Cancer|June 20, 2020
Breast cancer screening of mutation carriers in the era of COVID-19 pandemicAngela Toss, Matteo Lambertini, Kevin Punie, et al.
Open Access Journal of Contraception|December 16, 2024
Contraception Use in Cancer Survivors, Clinical Practice and Patients' PreferencesGiorgia Asinaro, Sara Stigliani, Edoardo Chiappe, et al.
The Cochrane Database of Systematic Reviews|May 28, 2016
Follow-up strategies for women treated for early breast cancerIvan Moschetti, Michela Cinquini, Matteo Lambertini, et al.
Breast Cancer Research and Treatment|June 23, 2022
Comment on "Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta‑analysis"Francesca Poggio, Marcello Ceppi, Piero Fregatti, et al.
Current Opinion in Oncology|May 3, 2017
Controversies about fertility and pregnancy issues in young breast cancer patients: current state of the artMatteo Lambertini, Oranite Goldrat, Florian Clatot, et al.
Ecancermedicalscience|August 3, 2022
Awareness and practices of Arab oncologists towards oncofertility in young women with cancerLoay Kassem, Nawfel Mellas, Marwan Tolba, et al.
Current Opinion in Oncology|July 16, 2024
Controversies on chemotherapy for early HR+/HER2- breast cancer: the role of anthracyclines and dose intensificationFrancesca Poggio, Chiara Molinelli, Irene Giannubilo, et al.
ESMO Open|February 22, 2018
ESMO Leaders Generation Programme: an alumni insightLeticia De Mattos Arruda, Carmen Criscitiello, Matteo Lambertini, et al.
Pageof 38

Showing results (51-60 of 375) with videos related to

Sort By:
Pageof 38
Annals of Palliative Medicine|April 3, 2020
Moving trastuzumab emtansine (T-DM1) to the early setting of breast cancer treatmentLuca Arecco, Eva Blondeaux, Alessandra Damassi, et al.
Breast Care (Basel, Switzerland)|May 14, 2020
Highlights from the San Antonio Breast Cancer Symposium (SABCS) 2019Isabell Witzel, Matteo Lambertini, Marija Balic, et al.
International Journal of Cancer|June 20, 2020
Breast cancer screening of mutation carriers in the era of COVID-19 pandemicAngela Toss, Matteo Lambertini, Kevin Punie, et al.
Open Access Journal of Contraception|December 16, 2024
Contraception Use in Cancer Survivors, Clinical Practice and Patients' PreferencesGiorgia Asinaro, Sara Stigliani, Edoardo Chiappe, et al.
The Cochrane Database of Systematic Reviews|May 28, 2016
Follow-up strategies for women treated for early breast cancerIvan Moschetti, Michela Cinquini, Matteo Lambertini, et al.
Breast Cancer Research and Treatment|June 23, 2022
Comment on "Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta‑analysis"Francesca Poggio, Marcello Ceppi, Piero Fregatti, et al.
Current Opinion in Oncology|May 3, 2017
Controversies about fertility and pregnancy issues in young breast cancer patients: current state of the artMatteo Lambertini, Oranite Goldrat, Florian Clatot, et al.
Ecancermedicalscience|August 3, 2022
Awareness and practices of Arab oncologists towards oncofertility in young women with cancerLoay Kassem, Nawfel Mellas, Marwan Tolba, et al.
Current Opinion in Oncology|July 16, 2024
Controversies on chemotherapy for early HR+/HER2- breast cancer: the role of anthracyclines and dose intensificationFrancesca Poggio, Chiara Molinelli, Irene Giannubilo, et al.
ESMO Open|February 22, 2018
ESMO Leaders Generation Programme: an alumni insightLeticia De Mattos Arruda, Carmen Criscitiello, Matteo Lambertini, et al.
Pageof 38